Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification
British Journal of Haematology · 2023-09 · 202 (5) · 1024-1032
DOI: 10.1111/bjh.18943 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 06.07.2023. Verfasst von Caterina Nannelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase Deficiency. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in erythrocytes causes acute haemolytic anaemia upon exposure to fava beans, drugs, or infection; and it predisposes to neonatal jaundice. The polymorphism of the X‐linked G6PD gene has been studied extensively: allele frequencies of up to 25% of different G6PD deficient variants are known in many populations; variants that cause chronic non‐spherocytic haemolytic anaemia (CNSHA) are instead all rare. WHO recommends G6PD testing to guide 8‐aminoquinolines administration to prevent relapse of Plasmodium vivax infection. From a literature review focused on polymorphic G6PD variants we have retrieved G6PD activity values of 2291 males, and for the mean residual red cell G6PD activity of 16 common variants we have obtained reliable estimates, that range from 1.9% to 33%. There is variation in different datasets: for most variants most G6PD deficient males have a G6PD activity below 30% of normal. There is a direct relationship between residual G6PD activity and substrate affinity ( K m G6P ), suggesting a mechanism whereby polymorphic G6PD deficient variants do not entail CNSHA. Extensive overlap in G6PD activity values of individuals with different variants, and no clustering of mean values above or below 10% support the merger of class II and class III variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Florence, Florence, Italy.
- Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Core Research Laboratory, Florence, Italy.
- World Health Organisation, Global Malaria Programme, Geneva, Switzerland.
- School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
- Cancer Council Victoria, Melbourne, Victoria, Australia.
- Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Lucio Luzzatto
Förderung
- World Health Organization
Zitieren
APA
Nannelli, C., Bosman, A., Cunningham, J., Dugué, P. A., & Luzzatto, L. (2023). Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification. British Journal of Haematology, 202(5), 1024-1032. https://doi.org/10.1111/bjh.18943
Vancouver
Nannelli C, Bosman A, Cunningham J, Dugué PA, Luzzatto L. Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification. British Journal of Haematology. 2023;202(5):1024-1032. doi:10.1111/bjh.18943
BibTeX
@article{Nannelli2023,
author = {Nannelli, Caterina and Bosman, Andrea and Cunningham, Jane and Dugué, Pierre-Antoine and Luzzatto, Lucio},
title = {Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification},
journal = {British Journal of Haematology},
year = {2023},
volume = {202},
number = {5},
pages = {1024--1032},
doi = {10.1111/bjh.18943}
}
EUVIMED